When you’re pregnant, your blood contains fragments of your baby’s DNA. A non-invasive prenatal test (NIPT) is a new type of screening test that analyses this circulating DNA in a sample of your blood to predict the risk of your baby having certain genetic abnormalities. Collecting your blood sample for NIPT poses no threat to your baby. It is possible from week 10 of your pregnancy.
inqaba biotec offers 4 distinct NIPT tests:
PrenaTest® Option 1 – for singleton pregnancies only – 5 500 ZAR (VAT incl.)
This test option screens for the presence of the most common chromosomal abnormality – Trisomy 21 (Down syndrome) – and it also allows for gender determination of the baby on request.
CentoNIPT® – for singleton and twin pregnancies – ZAR 6000 ZAR (VAT incl.)
This test option screens for the presence of Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome), Trisomy 13 (Patau syndrome), Sex chromosome aneuploidies and gender determination of the baby on request.
GeneSafe INHERITED – Test screens for 5 common inherited recessive genetic disorders: Cystic Fibrosis, Beta-Thalassemia, Sickle cell anaemia, Deafness autosomal recessive type 1A, Deafness autosomal recessive type 1B. – ZAR 14 128 (incl. VAT)
GeneSafe De Novo – Test screens for 44 severe genetic disorders, which arise as a result of a De Novo mutation in 25 genes. Please click here) for list of genes. – ZAR 14 128 (incl. VAT)
GeneSafe Combined – Test screens for inherited and De Novo mutations as listed above – ZAR 20 468 (incl. VAT)
PaternitySAFE – Test is available from week 11 of gestation and screens for paternity – ZAR 29 509 (incl. VAT)
For more information and/or to order a kit, please contact us on:
Tel: 012 343 5829
Genetic counselling support is available on request for patients with positive or negative test results.